Document is current
Any future updates will be listed below
-
Authors
Ailumerab, Haider
Miller, Jamie L. https://orcid.org/0000-0003-2637-2550
DeShea, Lise https://orcid.org/0000-0003-3232-5216
Beasley, William Howard
Chaaban, Hala https://orcid.org/0000-0002-7112-564X
Bergner, Erynn M. https://orcid.org/0000-0002-8607-3002
- License Information
-
More Information
Article History
Received: 22 November 2024
Revised: 28 March 2025
Accepted: 19 August 2025
First Online: 30 August 2025
Competing interests
: The authors have no conflicts of interest relevant to this article to disclose. EMB previously served as the Site PI for Prolacta Biosciences® unrelated trial on infants with congenital bowel disorders (2019-2023) for which the institution received research support. The other authors have no conflicts of interest to disclose.
